NEKENZIE JONES: Open Payments
NPI 1649936535 · SAINT GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,562 in 108 payments from 18 companies in 2025. Trend: 2023 $1,698 · 2024 $1,790 · 2025 $2,562
Food & beverage: $2,511Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $598 |
| Janssen Biotech, Inc. | 16 | $378 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $260 |
| Ardelyx, Inc. | 9 | $247 |
| Madrigal Pharmaceuticals | 9 | $241 |
| Regeneron Healthcare Solutions, Inc. | 6 | $205 |
| Ipsen Biopharmaceuticals, Inc | 3 | $136 |
| Lilly USA, LLC | 3 | $93 |
| Intercept Pharmaceuticals, Inc. | 4 | $70 |
| Gilead Sciences, Inc. | 4 | $67 |
Products named: TREMFYA, RINVOQ, IBSRELA, DUPIXENT, ENTYVIO, REZDIFFRA, SKYRIZI, IQIRVO.
Industry payments across UT — which companies pay providers there.
